HEPA

Hepion Pharmaceuticals
HEPA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

HEPA was delisted on the 12th of May, 2025.

Back to rankings

4 hedge funds and large institutions have $1.44K invested in Hepion Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.39K
2
+$52

Top Sellers

1
-$360K
2
-$45.4K
3
-$7K
4
Citadel Advisors
Citadel Advisors
Florida
-$6.7K
5
BlackRock
BlackRock
New York
-$713
Name Holding Trade Value Shares
Change 		Change in
Stake
XT
1
XTX Topco
Cayman Islands
$1.39K
Osaic Holdings
2
Osaic Holdings
Arizona
$53
SM
3
Sabby Management
Florida
–
AFM
4
Anson Funds Management
Texas
–
HF
5
HRT Financial
New York
–
Citadel Advisors
6
Citadel Advisors
Florida
–
BlackRock
7
BlackRock
New York
–
PNC Financial Services Group
8
PNC Financial Services Group
Pennsylvania
–
TRCT
9
Tower Research Capital (TRC)
New York
–
Fidelity Investments
10
Fidelity Investments
Massachusetts
–
SS
11
SBI Securities
Japan
–
Morgan Stanley
12
Morgan Stanley
New York
–
Group One Trading
13
Group One Trading
Illinois
–
FDCDDQ
14
Federation des caisses Desjardins du Quebec
Quebec, Canada
–
AF
15
Allworth Financial
California
–